DRUG BINDING INTERFACES MAPPED TO 'ERLOTINIB'

List of Binding Interfaces
(Click on the entry ID to view details of interfaces and pattern clusters)
(Note that ASSAM search use only 3-12 residue containing patterns)

Filter list by:

DrReposER ID	PDB	Ligand	Organism	Macromolecule	Pfam	Res.	Interface	HETATM
1M17_A_AQ4A999	1m17	AQ4 DB00530 (Erlotinib)	Homo sapiens	EPIDERMAL GROWTH FACTOR RECEPTOR	PF07714 (Pkinase_Tyr)	12	LEU A 694 ALA A 719 LYS A 721 GLU A 738 LEU A 764 THR A 766 LEU A 768 MET A 769 GLY A 772 LEU A 820 THR A 830 ASP A 831	AQ4 A 999
4HJO_A_AQ4A1001	4hjo	AQ4 DB00530 (Erlotinib)	Homo sapiens	EPIDERMAL GROWTH FACTOR RECEPTOR	PF07714 (Pkinase_Tyr)	14	LEU A 694 VAL A 702 ALA A 719 LYS A 721 LEU A 764 THR A 766 LEU A 768 MET A 769 GLY A 772 CYS A 773 ASP A 776 LEU A 820 THR A 830 ASP A 831	AQ4 A1001
6DWN_A_AQ4A602	6dwn	AQ4 DB00530 (Erlotinib)	Homo sapiens	CYTOCHROME P450 1A1	PF00067 (p450)	17	ILE A 115 SER A 116 SER A 122 ASN A 222 ASN A 223 PHE A 224 LEU A 254 ASN A 255 PHE A 258 ASP A 313 GLY A 316 ALA A 317 PHE A 319 ASP A 320 ILE A 386 LEU A 496 LYS A 499	AQ4 A 602
6DWN_B_AQ4B602	6dwn	AQ4 DB00530 (Erlotinib)	Homo sapiens	CYTOCHROME P450 1A1	None	19	ILE B 115 SER B 116 SER B 122 ASN B 222 ASN B 223 PHE B 224 PHE B 251 LEU B 254 ASN B 255 PHE B 258 ASP B 313 GLY B 316 ALA B 317 PHE B 319 ASP B 320 VAL B 382 ILE B 386 LEU B 496 LYS B 499	AQ4 B 602
6DWN_C_AQ4C602	6dwn	AQ4 DB00530 (Erlotinib)	Homo sapiens	CYTOCHROME P450 1A1	None	15	ILE C 115 SER C 116 SER C 120 SER C 122 ASN C 222 PHE C 224 LEU C 254 ASN C 255 PHE C 258 ASP C 313 GLY C 316 ALA C 317 PHE C 319 ILE C 386 LEU C 496	AQ4 C 602
6DWN_D_AQ4D602	6dwn	AQ4 DB00530 (Erlotinib)	Homo sapiens	CYTOCHROME P450 1A1	None	12	ILE D 115 SER D 122 ASN D 222 PHE D 224 PHE D 258 ASP D 313 GLY D 316 ALA D 317 PHE D 319 ASP D 320 ILE D 386 LEU D 496	AQ4 D 602

[["1M17_A_AQ4A999","1m17","AQ4","DB00530(Erlotinib)","Homo sapiens","EPIDERMAL GROWTH FACTOR RECEPTOR","PF07714(Pkinase_Tyr)",12,"LEU A 694;ALA A 719;LYS A 721;GLU A 738;LEU A 764;THR A 766;LEU A 768;MET A 769;GLY A 772;LEU A 820;THR A 830;ASP A 831","AQ4 A 999\r"],["4HJO_A_AQ4A1001","4hjo","AQ4","DB00530(Erlotinib)","Homo sapiens","EPIDERMAL GROWTH FACTOR RECEPTOR","PF07714(Pkinase_Tyr)",14,"LEU A 694;VAL A 702;ALA A 719;LYS A 721;LEU A 764;THR A 766;LEU A 768;MET A 769;GLY A 772;CYS A 773;ASP A 776;LEU A 820;THR A 830;ASP A 831","AQ4 A1001\r"],["6DWN_A_AQ4A602","6dwn","AQ4","DB00530(Erlotinib)","Homo sapiens","CYTOCHROME P450 1A1","PF00067(p450)",17,"ILE A 115;SER A 116;SER A 122;ASN A 222;ASN A 223;PHE A 224;LEU A 254;ASN A 255;PHE A 258;ASP A 313;GLY A 316;ALA A 317;PHE A 319;ASP A 320;ILE A 386;LEU A 496;LYS A 499","AQ4 A 602\r"],["6DWN_B_AQ4B602","6dwn","AQ4","DB00530(Erlotinib)","Homo sapiens","CYTOCHROME P450 1A1","None",19,"ILE B 115;SER B 116;SER B 122;ASN B 222;ASN B 223;PHE B 224;PHE B 251;LEU B 254;ASN B 255;PHE B 258;ASP B 313;GLY B 316;ALA B 317;PHE B 319;ASP B 320;VAL B 382;ILE B 386;LEU B 496;LYS B 499","AQ4 B 602\r"],["6DWN_C_AQ4C602","6dwn","AQ4","DB00530(Erlotinib)","Homo sapiens","CYTOCHROME P450 1A1","None",15,"ILE C 115;SER C 116;SER C 120;SER C 122;ASN C 222;PHE C 224;LEU C 254;ASN C 255;PHE C 258;ASP C 313;GLY C 316;ALA C 317;PHE C 319;ILE C 386;LEU C 496","AQ4 C 602\r"],["6DWN_D_AQ4D602","6dwn","AQ4","DB00530(Erlotinib)","Homo sapiens","CYTOCHROME P450 1A1","None",12,"ILE D 115;SER D 122;ASN D 222;PHE D 224;PHE D 258;ASP D 313;GLY D 316;ALA D 317;PHE D 319;ASP D 320;ILE D 386;LEU D 496","AQ4 D 602\r"]]